Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares Genomics Immunology and Healthcare ETF (IDNA) and Invesco Dynamic Biotechnology & Genome ETF (PBE) belong to the same industry segment: BioTech & Genomics. Both ETFs have the same top 3 sector exposures: and Health Care. IDNA is less expensive with a Total Expense Ratio (TER) of 0.47%, versus 0.58% for PBE. IDNA is up 10.27% year-to-date (YTD) with +$6M in YTD flows. PBE performs worse with -7.11% YTD performance, and +$135K in YTD flows. Run a side-by-side ETF comparison of IDNA and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IDNA PBE | +0.52%-5.55% | +10.05%-4.87% | +10.27%-7.11% | +33.25%+17.56% | +29.09%+26.51% | -35.97%+3.80% |
| Flows | IDNA PBE | +$6M-$3M | +$6M+$969K | +$6M+$135K | +$2M-$32M | -$21M-$56M | +$479K-$39M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IDNA PBE | +23.81%+19.01% | +25.77%+22.33% | +24.07%+20.20% | +28.18%+22.79% |
| Max drawdown | IDNA PBE | -7.09%-11.05% | -18.64%-16.18% | -30.61%-22.21% | -68.19%-34.74% |
| Max drawdown duration | IDNA PBE | 11d64d | 127d107d | 279d324d | 1635d1540d |
IDNA | PBE | |
Last sale 3/12/2026 at 1:30 PM | $28.91 | $76.18 |
| Previous close 03/12/2026 | $29.96 | $78.26 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IDNA | PBE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IDNA | PBE | |
|---|---|---|
| Last price | $28.91 | $76.18 |
| 1D performance | -3.50% | -2.66% |
| AuM | $150.13 M | $240.98 M |
| E/R | 0.47% | 0.58% |
IDNA | PBE | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | Invesco |
| Benchmark | NYSE FactSet Global Genomics and Immuno Biopharma Index | Dynamic Biotech & Genome Intellidex Index |
| N° of holdings | 42 | 30 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 11, 2019 | June 23, 2005 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.